ADMA - ADMA Biologics GAAP EPS of -$0.03 in-line revenue of $60.13M beats by $4.63M
2023-08-09 16:20:32 ET
- ADMA Biologics press release ( NASDAQ: ADMA ): Q2 GAAP EPS of -$0.03 in-line.
- Revenue of $60.13M (+77.4% Y/Y) beats by $4.63M .
- FY2024 and 2025 Total Revenue Guidance Increased to $275 Million vs $226.03M consensus and $325 Million or More, Respectively
For further details see:
ADMA Biologics GAAP EPS of -$0.03 in-line, revenue of $60.13M beats by $4.63M